Tag: Acquisition
News
Samsung Biologics Launches CHF 1.46B Acquisition of PolyPeptide to Scale Peptide Capabilities
The global biopharmaceutical contract manufacturing sector is undergoing a rapid transition toward complex modalities as drug developers prioritize specialized treatments for metabolic and chronic...
Business & Industry
Merck KGaA to Acquire Bio-Techne for $11.3 Billion to Bolster Life Science Division
The German pharmaceutical group Merck KGaA announced that it has entered into a definitive agreement to purchase the United States-based biotechnology firm Bio-Techne for...
Business & Industry
AbbVie Acquires Apogee in $10.9 Billion Healthcare Deal
In a significant expansion of its research and development capabilities, a definitive agreement has been reached where AbbVie acquires Apogee Therapeutics for $10.9 billion....
Business & Industry
Sigma Healthcare Pursues Potential Boots Acquisition Deal
Australia’s Sigma Healthcare has confirmed that it is participating in discussions regarding a possible acquisition of Boots, the UK health and beauty retailer, in...
Business & Industry
Incyte Expands Haematology Portfolio with Vega Acquisition
Incyte has agreed to acquire Vega Therapeutics, a subsidiary of Star Therapeutics, in a transaction valued at up to $2bn, reinforcing its presence in...
Business & Industry
GSK Targets Nuvalent in $10.6 Billion Oncology Acquisition
GSK has agreed to acquire Nuvalent in a transaction valued at $10.6 billion, positioning the UK-based pharmaceutical company for its largest acquisition in more...
Business & Industry
Firefly Bio Acquisition Strengthens J&J Cancer Pipeline
Johnson & Johnson (J&J) has entered into a definitive agreement to acquire Firefly Bio for $1bn in cash, a move aimed at expanding its...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read